Literature DB >> 12919755

The preventable proportion of nosocomial infections: an overview of published reports.

S Harbarth1, H Sax, P Gastmeier.   

Abstract

The proportion of nosocomial infections potentially preventable under routine working conditions remains unclear. We performed a systematic review to describe multi-modal intervention studies, as well as studies assessing exogenous cross-infection published during the last decade, in order to give a crude estimate of the proportion of potentially preventable nosocomial infections. The evaluation of 30 reports suggests that great potential exists to decrease nosocomial infection rates, from a minimum reduction effect of 10% to a maximum effect of 70%, depending on the setting, study design, baseline infection rates and type of infection. The most important reduction effect was identified for catheter-related bacteraemia, whereas a smaller, but still substantial potential for prevention seems to exist for other types of infections. Based on these estimates, we consider at least 20% of all nosocomial infections as probably preventable, and hope that this overview will stimulate further research on feasible and cost-effective prevention of nosocomial infections for daily practice.

Entities:  

Mesh:

Year:  2003        PMID: 12919755     DOI: 10.1016/s0195-6701(03)00150-6

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  109 in total

1.  Preventing hospital-acquired infections: a national survey of practices reported by U.S. hospitals in 2005 and 2009.

Authors:  Sarah L Krein; Christine P Kowalski; Timothy P Hofer; Sanjay Saint
Journal:  J Gen Intern Med       Date:  2011-12-06       Impact factor: 5.128

2.  A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria.

Authors:  Luigi Segagni Lusignani; Alexander Blacky; Peter Starzengruber; Magda Diab-Elschahawi; Thomas Wrba; Elisabeth Presterl
Journal:  Wien Klin Wochenschr       Date:  2016-01-27       Impact factor: 1.704

3.  Aiming for zero: is complete elimination of catheter-related bloodstream infections among intensive care unit patients a realistic goal?

Authors:  John A Jernigan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

4.  What do central venous catheter-associated bloodstream infections have to do with bundles?g.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

5.  Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method.

Authors:  Diana F M Willemse-Erix; Maarten J Scholtes-Timmerman; Jan-Willem Jachtenberg; Willem B van Leeuwen; Deborah Horst-Kreft; Tom C Bakker Schut; Ruud H Deurenberg; Gerwin J Puppels; Alex van Belkum; Margreet C Vos; Kees Maquelin
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

6.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

7.  New antibacterials?

Authors:  Kevin B Laupland; David N Fisman
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 8.  Costs of hospital-acquired infection and transferability of the estimates: a systematic review.

Authors:  H Fukuda; J Lee; Y Imanaka
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

9.  Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters.

Authors:  Mariana Buss Cezar Fontana; Maria do Carmo Freire de Bastos; Adriano Brandelli
Journal:  Curr Microbiol       Date:  2006-04-01       Impact factor: 2.188

10.  The effect of surgical site infection on older operative patients.

Authors:  Keith S Kaye; Deverick J Anderson; Richard Sloane; Luke F Chen; Yong Choi; Katherine Link; Daniel J Sexton; Kenneth E Schmader
Journal:  J Am Geriatr Soc       Date:  2009-01       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.